A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PDAC

Search Conditions:
Search Keyword : PDAC
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: PDAC
Appearance Frequency: 8770 time(s)
Long forms: 51

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
pancreatic ductal adenocarcinoma
(8685 times)
Neoplasms
(3661 times)
OS (722 times)
EMT (282 times)
CI (247 times)
1996 Neurotrophin-Trk receptor interactions in neoplasia: a possible role in interstitial and perineural invasion in ductal pancreatic cancer.
poly(diallyldimethylammonium chloride)
(19 times)
Chemistry
(11 times)
PEM (5 times)
PSS (5 times)
SPS (5 times)
2004 Dip-pen nanolithography with poly(diallyl dimethyl ammonium) chloride.
pancreatic ductal cancer
(6 times)
Neoplasms
(3 times)
CE-EUS (1 time)
ctDNA (1 time)
EMT (1 time)
2017 [Bit1 mediates the malignant behaviors in pancreatic cancer and its potential clinical significance].
primary duodenal adenocarcinoma
(4 times)
Gastroenterology
(3 times)
PD (3 times)
SR (3 times)
CI (1 time)
2009 The surgical treatment and outcome for primary duodenal adenocarcinoma.
patients with ductal adenocarcinoma of the pancreas
(3 times)
Bioengineering
(1 time)
CA19-9 (1 time)
CEA (1 time)
GEO (1 time)
2008 The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death.
poor differentiated adenocarcinoma
(3 times)
Neoplasms
(2 times)
AdHGD (1 time)
MAC (1 time)
MDAC (1 time)
1988 [Pathologic study on the treatment-effect of hematoporphyrin derivative in carcinoma of the gastric cardia].
BACKGROUNDPancreatic ductal adenocarcinoma
(2 times)
Biomedical Research
(1 time)
alpha-SMA (1 time)
CK-19 (1 time)
OBP (1 time)
2022 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.
pancreatic ductal
(2 times)
Medicine
(1 time)
EVs (1 time)
2015 CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
pancreatic head
(2 times)
Radiology
(1 time)
CT (1 time)
2019 Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head.
10  Placenta Derived Adherent Cell
(2 times)
Wounds and Injuries
(1 time)
BrdU (1 time)
GAGs (1 time)
MCAO (1 time)
2008 Placenta Derived Adherent Cell (PDAC) Interaction and Response on Extracellular Matrix Isolated from Human Placenta t.
11  poly(dimethyldiallylammonium chloride)
(2 times)
Chemistry
(1 time)
DOPC (1 time)
FRAPP (1 time)
LbL (1 time)
2006 Arrays of lipid bilayers and liposomes on patterned polyelectrolyte templates.
12  BIOT-NFL-PEG-AuNPs to target the destruction of pancreatic cancer cells
(1 time)
BIOT-NFL (1 time)
2022 NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC).
13  destroying pancreatic cancer cells
(1 time)
BIOT-NFL (1 time)
CPP (1 time)
DLS (1 time)
2022 Cell penetrating peptide (CPP) gold(iii) - complex - bioconjugates: from chemical design to interaction with cancer cells for nanomedicine applications.
14  pancreas adenocarcinoma
(1 time)
General Surgery
(1 time)
NAT (1 time)
UR (1 time)
2020 Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
15  pancreas and are of the ductal adenocarcinoma histological subtype
(1 time)
Molecular Biology
(1 time)
--- 2016 Molecular Pathogenesis of Pancreatic Cancer.
16  pancreas and pancreatic cancer
(1 time)
Neoplasms
(1 time)
MACE (1 time)
miRNAs (1 time)
2015 Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
17  pancreatic adenocarcinoma cell lines
(1 time)
Cell Physiological Processes
(1 time)
AMPK (1 time)
BBR (1 time)
2019 Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.
18  pancreatic cells including ductal adenocarcinoma
(1 time)
General Surgery
(1 time)
--- 2015 Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
19  pancreatic ductal system
(1 time)
Neoplasms
(1 time)
--- 2017 MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.
20  pancreatic lesions, by one in ductal adenocarcinoma
(1 time)
General Surgery
(1 time)
LOS (1 time)
ODP (1 time)
POPF (1 time)
2016 Laparoscopic distal pancreatectomy: many meta-analyses, few certainties.
21  pancreatic tumors are invasive ductal adenocarcinoma
(1 time)
General Surgery
(1 time)
--- 2012 Histopathologic assessment of pancreatic cancer: does one size fit all?
22  pancreatoduodenectomy and the pancreatic adenocarcinoma
(1 time)
Neoplasms
(1 time)
Apaf-1 (1 time)
2020 Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer.
23  parenchyma and ductal adenocarcinomas
(1 time)
Radiology
(1 time)
CECT (2 times)
CCC (1 time)
2019 Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
24  path-dependent attenuation correction
(1 time)
Diagnostic Imaging
(1 time)
ED (1 time)
ES (1 time)
LV (1 time)
1986 Attenuation correction in echocardiography.
25  patient survival in both malignant exocrine and ductal adenocarcinomas
(1 time)
Medicine
(1 time)
HR (1 time)
2013 Somatic mutations in exocrine pancreatic tumors: association with patient survival.
26  patients diagnosed with pancreatic cancer
(1 time)
Neoplasms
(1 time)
--- 2018 Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
27  patients suffering from a ductal adenocarcinoma of the pancreas
(1 time)
Gastroenterology
(1 time)
--- 2010 Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
28  patients with adenocarcinoma
(1 time)
Chemistry
(1 time)
DM (1 time)
FLIM (1 time)
STZ (1 time)
2022 Contrast-Free FLIM Reveals Metabolic Changes in Pathological Islets of Langerhans.
29  PC ductal adenocarcinomas
(1 time)
MMR (1 time)
NGS (1 time)
PARPi (1 time)
2022 OncoPan: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma.
30  PDA capsule
(1 time)
DOX (1 time)
PAI (1 time)
PDAP (1 time)
2017 Polydopamine Nanocapsule: A Theranostic Agent for Photoacoustic Imaging and Chemo-Photothermal Synergistic Therapy.
31  PDAC cocultured with PSC
(1 time)
Neoplasms
(1 time)
hPSC (1 time)
NFV (1 time)
2016 The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.
32  PDAC-exosomes
(1 time)
Neoplasms
(1 time)
DDSs (1 time)
PC (1 time)
2022 Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
33  photonic digital-to-analog converter
(1 time)
Ophthalmology
(1 time)
ODQPSK (1 time)
2012 Novel 2N bit bipolar photonic digital-to-analog converter based on optical DQPSK modulation coupled with differential detection.
34  PMH and FH of pancreatic
(1 time)
General Surgery
(1 time)
FDR (1 time)
2017 Cancer history: A predictor of IPMN subtype and dysplastic status?
35  Podocalyxin overexpression associates with poor survival in pancreatic cancer
(1 time)
Natural Science Disciplines
(1 time)
--- 2021 Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer.
36  polarization-switching digital-to-analog converter
(1 time)
Nuclear Medicine
(1 time)
--- 2005 Polarization-switching D/A converter.
37  polyamine deacetylase
(1 time)
Biochemistry
(1 time)
HDACs (1 time)
2022 First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement.
38  poor survival,pancreatic ductal adenocarcinoma
(1 time)
General Surgery
(1 time)
TSR (1 time)
2020 [Overview of tumor stroma ratio in pancreatic ductal adenocarcinoma].
39  poorly differentiated pancreatic adenocarcinoma
(1 time)
Neoplasms
(1 time)
DEGs (1 time)
GEPIA (1 time)
PPI (1 time)
2021 Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma.
40  potentially resectable ductal adenocarcinoma
(1 time)
Gastroenterology
(1 time)
PTO (1 time)
2019 Patients' treatment preferences for potentially resectable tumors of the head of the pancreas.
41  pregnancy day assessment
(1 time)
Medicine
(1 time)
BP (1 time)
PE (1 time)
2015 Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital.
42  present day average crustal ratios
(1 time)
Environmental Health
(1 time)
KML (1 time)
2010 A study of radionuclides, metals and stable lead isotope ratios in sediments and soils in the vicinity of natural U-mineralisation areas in the Northern Territory.
43  primary ductal adenocarcinoma of the pancreas
(1 time)
Cell Physiological Phenomena
(1 time)
PMRCC (1 time)
2013 Pancreatic metastases of renal clear cell carcinoma: a clinicopathological study of 11 cases with special emphasis on the usefulness of PAX2 and mesothelin for the distinction from primary ductal adenocarcinoma of the pancreas.
44  prognosis associated with pancreatic cancer
(1 time)
Gastroenterology
(1 time)
--- 2015 Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
45  propofol, an anesthesia drug, in suppressing pancreatic cancer
(1 time)
Pharmacology
(1 time)
ADAM8 (1 time)
2020 Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
46  prostatic duct adenocarcinoma
(1 time)
Clinical Laboratory Techniques
(1 time)
DE (1 time)
DP (1 time)
DSen (1 time)
2006 [Evaluation of the diagnostic significance of cytologic studies in pancreatic tumors].
47  psychodisadaptation conditions
(1 time)
Neurology
(1 time)
--- 1989 [Classification and psychological prevention of pre-nosological forms of borderline conditions occurring in the Northern Siberia].
48  Psychopharmacologic Drug Advisory Committee
(1 time)
Evidence-Based Medicine
(1 time)
COIs (1 time)
FDA (1 time)
2020 Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
49  Pulmonary hypoplasia-diaphragmatic hernia-anophthalmia-cardiac defect
(1 time)
Genetics, Medical
(1 time)
STRA6 (1 time)
2009 Pulmonary hypoplasia-diaphragmatic hernia-anophthalmia-cardiac defect (PDAC) syndrome due to STRA6 mutations--what are the minimal criteria?
50  pulmonary hypoplasia/agenesis, diaphragmatic hernia/eventration, anophthalmia/microphthalmia, and cardiac defect
(1 time)
Clinical Medicine
(1 time)
--- 2019 Microphthalmia Syndrome 9: Case Report of a Newborn Baby with Pulmonary Hypoplasia, Diaphragmatic Eventration, Microphthalmia, Cardiac Defect and Severe Primary Pulmonary Hypertension.
51  type, ductal adenocarcinoma
(1 time)
Molecular Biology
(1 time)
CI (1 time)
COX-2 (1 time)
IKK2 (1 time)
2016 Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.